The period of time before ovarian cancer recurred (called progression - free survival) improved by nearly 3.5 months with the additional drug (13.8 months compared with 10.4 months for the woman
on chemotherapy alone).
Not exact matches
Working with mouse models of cancer, they demonstrated how treatment with antibiotics
on top of
chemotherapy may be significantly superior to treatment with
chemotherapy alone.
They found this was
on average 14.1 months in the group having
chemotherapy and cetuximab compared to 20.5 months in the group having
chemotherapy alone.
The study, published in November 2016 in The Lancet Oncology and presented with updated outcomes at the October 2017 World Conference
on Lung Cancer in Yokohama, Japan, reported that 57 percent of patients receiving the combination therapy responded to treatment, whereas only 31 percent responded to
chemotherapy alone.
Depending
on the nature of a mammary tumor, treatment may not be necessary, surgery
alone, or surgery in combination with
chemotherapy.
Prognosis of patients with this disease depends
on multiple factors, the most commonly cited including: presence of metastasis (negative), elevated alkaline phosphatase (negative), large tumor size (negative), humerus location (negative), treatment chosen (dogs receiving amputation and
chemotherapy have improved survival times over dogs receiving amputation
alone) 1.